Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Brain Neoplasms 12Central Nervous System Neoplasms 11Glioblastoma 10Gliosarcoma 8Glioma 7Astrocytoma 4Oligodendroglioma 3Neuroblastoma 3Melanoma 3Medulloblastoma 3Sarcoma 2Recurrence 2Osteosarcoma 2Neuroectodermal Tumors, Primitive 2Neoplasms 2Ependymoma 2Wilms Tumor 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma, Kaposi 1Sarcoma, Ewing 1Salivary Gland Neoplasms 1Rhabdomyosarcoma 1Retinoblastoma 1Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pinealoma 1

Interventions

Thalidomide 1Etoposide 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brainstem Glioma × Thalidomide × CNS × Clear all
NCT01756989 2014-05-08

ANGIOCOMB Antiangiogenic Therapy for Pediatric Patients With Diffuse Brain Stem and Thalamic Tumors

Helsinki University Central Hospital

Phase 2 Completed
50 enrolled
CNS

Brainstem Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡